item management s discussion and analysis of financial condition and results of operations the following discussion of the results of operations and financial condition of the company should be read in conjunction with the consolidated financial statements and the notes thereto included elsewhere in this annual report on form k 
certain factors that may affect future results the company s actual results could differ materially from its historical results or from any forward looking statements made or incorporated into this annual report 
factors that may cause such differences include the company s ability to successfully enter in to new contractual alliances with physician organizations and to preserve its existing contractual relationships  the company s ability to successfully expand its business to new markets  the company s ability to attract and retain qualified personnel and management  changes in state insurance laws and related government regulations  increased competition and growth in the medical practice management market  and other unanticipated changes in economic conditions 
overview advanced health corporation the company provides a full range of integrated management services and clinical information systems to physician group practices  single legal entities comprised of multiple physicians  and to physician networks  aggregations of individual physicians and physician groups formed for the purpose of entering into contracts with third party payors 
the company s clinical information systems are also licensed to hospitals  integrated delivery systems  information system companies  and other health care organizations 
the company generates revenues from i fees for managing and providing consulting services to physician group  practices  ii fees for managing physician networks and iii fees for use and support of its clinical information systems  including licensed  software installation  software integration  training and data conversion fees 
the company contracts with its physician practice and network management clients pursuant to long term agreements with its msos  the financial results of such msos are included in the consolidated financial statements 
the company believes that its historical results of operations from period to period are not comparable and that such results are not necessarily indicative of results for any future periods because the company was a development stage company investing in technology development and did not provide physician practice and network management services prior to december  results of operations year ended december  and total revenues for the year ended december  increased to million from million in the year ended december   primarily as a result of the addition of new physician group practices under management  provision of incremental network management services and fees for the use and support of clinical information systems 
the provision of physician group practice management and related services and network management services accounted for approximately million of the company s net revenues for the year ended december  as compared to million in the year ended december  the company earned fees for the use and support of its clinical information systems  including the recognition of license revenues and software  systems and training revenues  of approximately million for the year ended december   as compared to million in the year ended december  of the million of information technology revenues  approximately million were earned in connection with software licenses or information management service fees with affiliated entities or with entities in which the company has a minority equity interest 
cost of revenues for the year ended december  increased to million from approximately million for the year ended december  the increase in cost of revenues related primarily to the expenses outsourced to the company from physician group practices under management 
operating expenses for the year ended december  increased to million from million for the year ended december  and included approximately 
million and of research and development costs respectively 
the increase in operating expenses related to the increased provision of physician group practice management and related services 
for the year ended december   the company also earned interest income in the amount of million from investments in marketable securities as a result of the investment proceeds from the ipo and follow on offerings 
the company earned interest income in the amount of 
million from investments in marketable securities as a result of the investment of proceeds from the ipo for the comparable period ended december  the company incurred interest expense of approximately 
million for the period ending december   which related primarily to interest on million of then outstanding indebtedness bearing interest at per annum million  per annum million and interest on capital lease obligations 
an income tax benefit of approximately million was recorded in as a result of the company s determination  based on profitable fourth quarter operations  that the related deferred income tax asset would be realized through the generation of taxable income in the future 
the net income for the year ended december  was million compared to a loss of million for the year ended december  due to the factors describe above 
year ended december  and total revenues for the year ended december  increased to million from million in the year ended december   primarily as a result of the addition of new physician group practices under management  provision of incremental network management services and fees for the use and support of its clinical information systems 
the company began to provide physician network management services in september and physician group practice management and related services in december the provision of physician group practice management and related services and network management services accounted for approximately million of the company s net revenue in the year ended december  as compared to 
million for the comparable period ended december  the company earned fees for the use and support of its clinical information systems  including the recognition of license revenues and software systems  and from revenues of approximately million for the year ended december   as compared to 
million for the comparable period ended december  operating expenses for the year ended december  increased to million from million for the year ended december  the increase in operating expenses was due to the increases in staffing and general corporate expenses required to fund the company s transition from a development stage company involved in the development of clinical information systems to a full service physician practice and network management company 
the net loss for the year ended december  was million compared to a loss of million for the year ended december  liquidity and capital resources at december   the company had aggregate cash  cash equivalents  certificates of deposit and marketable securities of million  compared to million at december  the cash flow from operations in was million versus a net use of cash of million in this increase in net cash from operations resulted primarily from an million increase in net income 
net cash used in investing activities grew from million in to million in this increase was due to several factors  including the investment in marketable securities of the proceeds of the company s follow on equity offering  the acquisition of bukstel halfpenny  a company that develops and provides software that links physicians with hospital based clinical systems such as laboratory  radiology and pathology systems  a minority investment in patient care dynamics  a compnay that provides an integrated family of technology based patient care support systems and services to physicians  a minority investment and loan to acrm  an organization that will provide advanced cardiovascular research management  a minority investment in caresoft  a developer of disease management tools  and capitalized software development costs 
cash flow from financing activities grew to million in from million in the net cash provided by financing activities in was primarily attributable to the company s public offering of common stock in october  which raised net proceeds of million 
the company s operating plan for includes continued development of the company s integrated management services and clinical information systems 
the principal categories of expenditures include further development of the company s clinical information systems  as well as ongoing business development and marketing 
the company believes that the net proceeds of the follow on equity offering together with other  cash and investments on hand  interest income and revenues from operations will be sufficient to fund planned operations of the company through at least mid during january and february  the company loaned million to madison  a physician practice it currently manages  secured by the physicians ownership interest in its mso 
the loan bears interest at prime plus percent and is to be repaid in equal monthly installments beginning january furthermore  the company provided a letter of credit on behalf of madison that expires january   in the amount of million by depositing restricted cash with the lending institution that issued the letter of credit 
the company has no other planned material capital expenditures or other capital commitments 
from time to time in the ordinary course of its business  the company evaluates possible acquisitions of businesses  products and technologies that are complementary to those of the company 
under certain specified circumstances  the company has the option to cause certain msos to be merged with and into a wholly owned subsidiary of the company in a transaction in which the interests of the physician groups and networks in such msos would be exchanged for common stock of the company 
the company has reserved  shares of common stock for issuance upon consummation of the roll up transaction  all of which will be issued if the company effects the roll up transaction 
in addition  certain of the physician groups and networks managed by the company have rights to require the company to purchase all or part of such physicians interest in their respective mso in the event that the company does not consummate the roll up transaction within one year after the satisfaction of specified conditions 
there can be no assurance that the company will have the financial resources to purchase such interests in accordance with its obligations at the time any such rights are exercised  or that the company would be able to obtain financing on satisfactory terms or conditions  if at all  to purchase such interests 
in addition  pursuant to its agreement with one of its physician group practice clients  the company has agreed  under certain circumstances  to advance funds to such group practice to finance working capital 
to date  the company has not made any advances to such group practice under the agreement and it does not expect to do so in the future 
year the year date change issue is believed to affect virtually all companies and organizations 
if not corrected  many computer applications could fail or create erroneous results by or at the year the company has not completed its assessment of compliance issues for the companys proprietary software products  for its computer systems both hardware and software  for equipment ancillary to the company s business that contains computers or computer chips  for the computer systems of other entities with which the company does business 
the company has also not determined the cost of these compliance issues or the time it will take to complete compliance 
the company expects to complete its full assessment of the year issue no later than december   which is prior to any anticipated impact on its operting systems 
as part of the year assessment  the company expects to communicate with all of its physician practices and networks  as well as suppliers and third parties with which the company does business  to determine the extent to which the company s interface systems are vulnerable to those parties failure to remedy their year issues 
there is no guarantee that the systems of other companies on which the compnay relies will be corrected in a timely manner or that the failure to correct will not have a material adverse effect on the company s systems 
year modifications and assessments are based on managements best estimates  which were derived utilizing numerous assumptions of future events  including availability of certain resources and other factors 
however  there can be no guarantee the estimates and assessments will be achieved or come to pass  and actual results could differ materially from those anticipated 

